e-learning
resources
Berlin 2001
Monday 24.09.2001
Lung cancer: surveys and prognosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gender and survival in lung cancer (LC): results of a healthcare study in WestGermany
S. Sohrab, U. Roggenbruck, K. H. Jöckel, N. Konietzko (Essen, Germany)
Source:
Annual Congress 2001 - Lung cancer: surveys and prognosis
Session:
Lung cancer: surveys and prognosis
Session type:
Thematic Poster Session
Number:
1583
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Sohrab, U. Roggenbruck, K. H. Jöckel, N. Konietzko (Essen, Germany). Gender and survival in lung cancer (LC): results of a healthcare study in WestGermany. Eur Respir J 2001; 16: Suppl. 31, 1583
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting?
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
TNM and survival in small cell lung cancer: results of a population-based study
Source: Eur Respir J 2001; 18: Suppl. 33, 394s
Year: 2001
Lung cancer survival in never smokers. Results from the LCRINS study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
Our operated lung cancer cases and their survival results
Source: Eur Respir J 2002; 20: Suppl. 38, 463s
Year: 2002
Prospective population-based study on the survival of patients with lung cancer
Source: Eur Respir J 2002; 19: 1087-1092
Year: 2002
Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC)
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
Determinants of the performance status in stage IV nonsmall cell lung cancer - results of a population-based study
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001
Survival outcomes in advance non-small cell lung cancer – A developing country scenario
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Time trends in treatment and survival of non-small cell lung cancer in The Netherlands
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Epidemiological and clinical predictors of survival during the first year of the treatment in non-small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Prognostic impact of socioeconomic status and health care access in non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
Chemotherapy improves low performance status lung cancer patients
Source: Eur Respir J 2007; 30: 1186-1192
Year: 2007
Symptom control in advanced non-small cell lung cancer (NSCLC): what is the influence of cisplatin-use, age, performance status and duration of chemotherapy? Analysis of a randomized database
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
Source: Eur Respir J 2011; 39: 9-28
Year: 2012
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
Source: Eur Respir J 2012; 39: 9-28
Year: 2012
A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015
The influence of secondary infectious process on non-small cell lung cancer (NSCLC) patients survival
Source: Eur Respir J 2007; 30: Suppl. 51, 280s
Year: 2007
Lung cancer and socioeconomic status: Differences in demographics, stage, treatment and mortality in a lung cancer centre
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept